Announcing IndieBio SF’s Next Wave – VC-Founder Meetings (June 17 to 21) Learn More

BioLattice

Revolutionizing Tissue Repair

Team

Linda Alunkal

COO

Company details

BioLattice Ophthalmics, Inc. is addressing the need for tissue repair solutions, beginning with cornea.

One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant.

Almost 13 million globally are on a donor cornea tissue waiting list. There is currently no standard of care alternative to donor cornea tissue for full thickness cornea transplant material.

Our engineered cornea will be a true alternative to donor cornea while also offering corrective vision.

Get In Touch with BioLattice

Please tell us a little bit about yourself and why you'd like to get connected. BioLattice + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.